CLASS II Drug recall · Reported 18 Apr 2018 · FDA Enforcement Report
Zhong Hua Jiu (menthol 1%) Patch recalled by United Pacific Co
United Pacific is recalling Zhong Hua Jiu (menthol 1%) Patch, distributed nationwide in the US. The recall was initiated on 29 Mar 2018 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0624-2018
- FDA event ID
- 79693
- Recalling firm
- United Pacific, South El Monte, CA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 29 Mar 2018
- FDA classified
- 10 Apr 2018
- Reported
- 18 Apr 2018
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Manufacturing (CGMP) Deviations
- Drug class
- Creams, Ointments & Gels
Timeline
| 29 Mar 2018 | Recall initiated by company | |
| 10 Apr 2018 | Classified by FDA | +12 days |
| 18 Apr 2018 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
CGMP Deviations: the product was produced with substandard GMP manufacturing processes.
Product as listed by the FDA
Zhong Hua Jiu (menthol 1%) Patch, Distributed by United Pacific Company, UPC 6 924938 100226, NDC 53614-001-02
Where it was distributed
Nationwide within US
Questions about this recall
Why was it recalled?
CGMP Deviations: the product was produced with substandard GMP manufacturing processes.
Which lots are affected?
Lot #:14122921, Exp.12/30/20119, 15091512, Exp. 9/15/2020, 6032321, Exp. 3/23/2021, 17030921, Exp. 3/09/2022
Where was it sold?
Nationwide within US
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.